Logistic regression model to predict chronic obstructive pulmonary disease exacerbation

Archives of Medical Science

Volumn 3, Issue 4, 2007, Pages 360-366

  Ghanei, Mostafa ^a   Aslani, Jafar ^a   Azizabadi Farahani, Mahdi ^a   Assari, Shervin ^a   Saadat, Seyed Hassan ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chronic obstructive pulmonary disease; Exacerbation; Hospitalization; Predicting factors

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; SOCIOECONOMICS; SPIROMETRY;

EID: 38949117950     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Vollmer WM, Osborne ML, Buist AS. 20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. Am J Respir Crit Care Med 1998; 157: 1079-84.
2. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI and WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Res Care 2001; 46: 798-825.
3. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52 (Suppl 5): S1-28.
4. Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001; 68: 4-19.
5. Renwick DS, Connolly MJ. Prevalence and treatment of chronic airways obstruction in adults over the age of 45. Thorax 1996; 51: 164-8.
6. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160: 1683-9.
7. Lundbäck B, Lindberg A, Lindström M, et al. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97: 115-22.
8. Sobradillo V, Miravitlles M, Jimenez CA, et al. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation [Spanish]. Arch Bronconeumol 1999; 35: 159-166.
9. Ray D, Abel R, Selvaraj KG. A 5-yr prospective epidemiological study of chronic obstructive pulmonary disease in rural south India. Indian J Med Res 1995; 101: 238-44.
10. Gudmundsson G, Gislason T, Janson C, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 2005; 26: 414-9.
11. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effects of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-22.
12. Connors AF Jr, Dawson NV, Thomas C, et al Outcomes following acute exacerbation of severe chronic obstructive disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996; 154: 959-67.
13. Andersson F, Borg S, Jansson SA, et al. The costs of exacerbations in chronic obstructive pulmonary disease. Respir Med 2002; 96: 700-8.
14. Office of National Statistics: Mortality statistics (revised) 1994, England and Wales, Her Majesty's Stationery Office, London 1996.
15. National Health Service Executive. Burdens of disease: a discussion document. Department of Health Leeds, United Kingdom 1996.
16. Sullivan, SD, Strassels, SA, Smith, DH. Characterization of the costs of chronic obstructive pulmonary disease (COPD) in the US [abstract]. Eur Respir J 1996; 9 (Suppl 23): 421S.
17. Garcia-Aymerich J, Farrero E, Félez MA, Izquierdo J, Marrades RM, Antó JM on behalf of the EFRAM investigators. Risk factors of re-admission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58: 100-5.
18. Garcia-Aymerich J, Monso E, Marrades RM, et al. EFRAM Investigators. Risk factors for hospitalisation for a chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 2001; 164: 1002-7.
19. Miravitlles M, Guerrero T, Mayordomo C, Sánchez-Agudo L, Nicolau F, Segú JL. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration 2000; 67: 495-501.
20. Osman IM, Godden DJ, Friend JA, Legge JS, Douglas JG. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997; 52: 67-71.
21. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 158-64.
22. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297-303.
23. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997; 10: 417-23.
24. Vestbo J, Sørensen T, Lange P, Brix A, Torre P, Viskum K. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999; 353: 1819-23.
25. Dales RE, Schweitzer I, Kerr P, Gougeon L, Rivington R, Draper J. Risk factors for recurrent emergency department visits for asthma. Thorax 1995; 50: 520-4.
26. Ifudu O, Paul HR, Homel P, Friedman EA. Predictive value of functional status for mortality in patients on maintenance hemodialysis. Am J Nephrol 1998; 18: 109-16.
27. Zigmond AS, Snaith PR. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
28. Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes 2003; 1: 14.
29. Bjelland I, Dahl AA, Tangen Haug T, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002; 52: 69-77.
30. Madison JM, Irwin RS. Chronic obstructive pulmonary disease. Lancet 1998; 352: 467-73.
31. Collet JP, Shapiro P, Ernst P, Renzi T, Ducruet T, Robinson A, the PARI-IS Study Steering Committee and Research Group. Effects of an immunostimulant agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 1719-24.
32. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856-61.
33. Dahlén I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 2002; 122: 1633-7.
34. Stehr DE, Klein BJ, Murata GH. Emergency department return visits in chronic obstructive pulmonary disease: the importance of psychosocial factors. Ann Emerg Med 1991; 20: 1113-6.
35. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry 2000; 15: 1090-6.
36. Harrison BD. Psychosocial aspects of asthma in adults. Thorax 1998; 53: 519-25.
37. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA 2000; 284: 2606-10.
38. Aghanwa HS, Erhabor GE. Specific psychiatric morbidity among patients with chronic obstructive pulmonary disease in a Nigerian general hospital. J Psychosom Res 2001; 50: 179-83.
39. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167: 60-7.
40. Pembroke TP, Rasul F, Hart CL, Davey Smith G, Stansfeld SA. Psychological distress and chronic obstructive pulmonary disease in the Renfrew and Paisley (MIDSPAN) study. J Epidemiol Community Health 2006; 60: 789-92.
41. Sirey JA, Raue PJ, Alexopoulos GS. An intervention to improve depression care in older adults with COPD. Int J Geriatr Psychiatry 2007; 22: 154-9.
42. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004; 58: 65-70.
43. Yohannes AM. Depression and COPD in older people: a review and discussion. Br J Community Nurs 2005; 10: 42-6.
44. Scognamiglio A, Matteelli G, Pistelli F, Baldacci S, Carrozzi L, Viegi G. Epidemiology of chronic obstructive pulmonary disease [Italian]. Ann Ist Super Sanita 2003; 39: 467-84.
45. Kim DS, Kim YS, Jung KS, et al. Korean Academy of Tuberculosis and Respiratory Diseases. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005; 172: 842-7.
46. Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J 1999; 13: 1109-14.
47. Singh RB, Singh V, Kulshrestha SK, et al. Social class and all-cause mortality in an urban population of North India Acta Cardiol 2005; 60: 611-7.
48. Viejo JL, Martín Escribano P, Romero S, Rodríguez Suárez JR, Sobradillo V, Valencia A. Compliance with inhalation treatment of patients with chronic obstructive pulmonary disease [Spanish]. Arch Bronconeumol 2000; 36: 319-25.
49. Adler NE, Newman K. Socioeconomic disparities in health: pathways and policies. Health Aff 2002; 21: 60-76.
50. Spence MM, Hui R, Chan J. Cost reduction strategies used by elderly patients with chronic obstructive pulmonary disease to cope with a generic-only pharmacy benefit. J Manag Care Pharm 2006; 12: 377-82.
51. Dormuth CR, Glynn RJ, Neumann P, Maclure M, Brookhart AM, Schneeweiss S. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma Clin Ther 2006; 28: 964-78; discussion 962-3.